Control of CD56 expression and tumor cell cytotoxicity in human Vγ2Vδ2 T cells

BMC Immunology

Volumn 10, Issue , 2009, Pages 50-

  Urban, Elizabeth M ^a   Li, Haishan ^a   Armstrong, Cheryl ^a   Focaccetti, Chiara ^a,b   Cairo, Cristiana ^a   Pauza, C David ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD56 ANTIGEN; ISOPRENOID; NERVE CELL ADHESION MOLECULE; PYROPHOSPHATE; T LYMPHOCYTE RECEPTOR;

ANTIGEN EXPRESSION; ARTICLE; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; EFFECTOR CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOSTIMULATION; LYMPHOCYTE CLONE; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; NORMAL HUMAN; PHENOTYPE; PRE T LYMPHOCYTE; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TUMOR CELL; VGAMMA2 VDELTA2 T LYMPHOCYTE;

ANTIGENS, CD56; ANTIGENS, DIFFERENTIATION; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CLONE CELLS; CYTOTOXICITY, IMMUNOLOGIC; GENE EXPRESSION REGULATION; HUMANS; IMMUNOLOGIC MEMORY; LYMPHOCYTE ACTIVATION; NEOPLASMS; POLYISOPRENYL PHOSPHATES; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTES, CYTOTOXIC;

EID: 70449381770     PISSN: None     EISSN: 14712172     Source Type: Journal    
DOI: 10.1186/1471-2172-10-50     Document Type: Article

References (28)

1. Lemster BH, Michel JJ, Montag DT, Paat JJ, Studenski SA, Newman AB, Vallejo AN. Induction of CD56 and TCR-independent activation of T cells with aging. J Immunol 2008, 180:1979-90.
2. Pittet MJ, Speiser DE, Valmori D, Cerottini JC, Romero P. Cutting edge: cytolytic effector function in human circulating CD8+ T cells closely correlates with CD56 surface expression. J Immunol 2000, 164:1148-52.
3. Romagnani C, Juelke K, Falco M, Morandi B, D'Agostino A, Costa R, Ratto G, Forte G, Carrega P, Lui G. CD56brightCD16- killer Ig-like receptor- NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation. J Immunol 2007, 178:4947-55.
4. Takahashi E, Kuranaga N, Satoh K, Habu Y, Shinomiya N, Asano T, Seki S, Hayakawa M. Induction of CD16+ CD56bright NK cells with antitumour cytotoxicity not only from CD16- CD56bright NK Cells but also from CD16- CD56dim NK cells. Scand J Immunol 2007, 65:126-38. 10.1111/j.1365-3083.2006.01883.x, 17257217.
5. Wajchman HJ, Pierce CW, Varma VA, Issa MM, Petros J, Dombrowski KE. Ex vivo expansion of CD8+CD56+ and CD8+CD56- natural killer T cells specific for MUC1 mucin. Cancer Res 2004, 64:1171-80. 10.1158/0008-5472.CAN-3254-2, 14871854.
6. Bauer S, Groh V, Wu J, Steinle A, Phillips JH, Lanier LL, Spies T. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 1999, 285:727-9. 10.1126/science.285.5428.727, 10426993.
7. Vilches C, Parham P. KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. Annu Rev Immunol 2002, 20:217-51. 10.1146/annurev.immunol.20.092501.134942, 11861603.
8. Godfrey DI, Berzins SP. Control points in NKT-cell development. Nat Rev Immunol 2007, 7:505-18. 10.1038/nri2116, 17589542.
9. Godfrey DI, MacDonald HR, Kronenberg M, Smyth MJ, Van Kaer L. NKT cells: what's in a name?. Nat Rev Immunol 2004, 4:231-7. 10.1038/nri1309, 15039760.
10. Bukowski JF, Morita CT, Tanaka Y, Bloom BR, Brenner MB, Band H. V gamma 2V delta 2 TCR-dependent recognition of non-peptide antigens and Daudi cells analyzed by TCR gene transfer. J Immunol 1995, 154:998-1006.
11. Davodeau F, Peyrat MA, Hallet MM, Gaschet J, Houde I, Vivien R, Vie H, Bonneville M. Close correlation between Daudi and mycobacterial antigen recognition by human gamma delta T cells and expression of V9JPC1 gamma/V2DJC delta-encoded T cell receptors. J Immunol 1993, 151:1214-23.
12. Hayday AC. [gamma][delta] cells: a right time and a right place for a conserved third way of protection. Annu Rev Immunol 2000, 18:975-1026. 10.1146/annurev.immunol.18.1.975, 10837080.
13. Hebbeler AM, Cairo C, Cummings JS, Pauza CD. Individual Vgamma2-Jgamma1.2+ T cells respond to both isopentenyl pyrophosphate and Daudi cell stimulation: generating tumor effectors with low molecular weight phosphoantigens. Cancer Immunol Immunother 2007, 56:819-29. 10.1007/s00262-006-0235-6, 17131122.
14. Davodeau F, Peyrat MA, Hallet MM, Houde I, Vie H, Bonneville M. Peripheral selection of antigen receptor junctional features in a major human gamma delta subset. Eur J Immunol 1993, 23:804-8. 10.1002/eji.1830230405, 8384559.
15. De Libero G, Casorati G, Giachino C, Carbonara C, Migone N, Matzinger P, Lanzavecchia A. Selection by two powerful antigens may account for the presence of the major population of human peripheral gamma/delta T cells. J Exp Med 1991, 173:1311-22. 10.1084/jem.173.6.1311, 2190840, 1827824.
16. Evans PS, Enders PJ, Yin C, Ruckwardt TJ, Malkovsky M, Pauza CD. In vitro stimulation with a non-peptidic alkylphosphate expands cells expressing Vgamma2-Jgamma1.2/Vdelta2 T-cell receptors. Immunology 2001, 104:19-27. 10.1046/j.1365-2567.2001.01282.x, 1783282, 11576216.
17. Alexander AA, Maniar A, Cummings JS, Hebbeler AM, Schulze DH, Gastman BR, Pauza CD, Strome SE, Chapoval AI. Isopentenyl pyrophosphate-activated CD56+ {gamma}{delta} T lymphocytes display potent antitumor activity toward human squamous cell carcinoma. Clin Cancer Res 2008, 14:4232-40. 10.1158/1078-0432.CCR-07-4912, 2614380, 18594005.
18. Parker CM, Groh V, Band H, Porcelli SA, Morita C, Fabbi M, Glass D, Strominger JL, Brenner MB. Evidence for extrathymic changes in the T cell receptor gamma/delta repertoire. J Exp Med 1990, 171:1597-612. 10.1084/jem.171.5.1597, 2187908, 2185330.
19. Cairo C, Propp N, Auricchio G, Armstrong CL, Abimiku A, Mancino G, Colizzi V, Blattner W, Pauza CD. Altered cord blood gammadelta T cell repertoire in Nigeria: possible impacts of environmental factors on neonatal immunity. Mol Immunol 2008, 45:3190-7. 10.1016/j.molimm.2008.02.029, 2601555, 18440637.
20. Thedrez A, Harly C, Morice A, Salot S, Bonneville M, Scotet E. IL-21-mediated potentiation of antitumor cytolytic and proinflammatory responses of human Vgamma9Vdelta2 T cells for adoptive immunotherapy. J Immunol 2009, 182:3423-31. 10.4049/jimmunol.0803068, 19265120.
21. Rincon-Orozco B, Kunzmann V, Wrobel P, Kabelitz D, Steinle A, Herrmann T. Activation of V gamma 9V delta 2 T cells by NKG2D. J Immunol 2005, 175:2144-51.
22. Wrobel P, Shojaei H, Schittek B, Gieseler F, Wollenberg B, Kalthoff H, Kabelitz D, Wesch D. Lysis of a broad range of epithelial tumour cells by human gamma delta T cells: involvement of NKG2D ligands and T-cell receptor-versus NKG2D-dependent recognition. Scand J Immunol 2007, 66:320-8. 10.1111/j.1365-3083.2007.01963.x, 17635809.
23. Yamashita S, Tanaka Y, Harazaki M, Mikami B, Minato N. Recognition mechanism of non-peptide antigens by human gammadelta T cells. Int Immunol 2003, 15:1301-7. 10.1093/intimm/dxg129, 14565928.
24. Allison TJ, Winter CC, Fournie JJ, Bonneville M, Garboczi DN. Structure of a human gammadelta T-cell antigen receptor. Nature 2001, 411:820-4. 10.1038/35081115, 11459064.
25. Miyagawa F, Tanaka Y, Yamashita S, Mikami B, Danno K, Uehara M, Minato N. Essential contribution of germline-encoded lysine residues in Jgamma1.2 segment to the recognition of nonpeptide antigens by human gammadelta T cells. J Immunol 2001, 167:6773-9.
26. Jensen KD, Su X, Shin S, Li L, Youssef S, Yamasaki S, Steinman L, Saito T, Locksley RM, Davis MM. Thymic selection determines gammadelta T cell effector fate: antigen-naive cells make interleukin-17 and antigen-experienced cells make interferon gamma. Immunity 2008, 29:90-100. 10.1016/j.immuni.2008.04.022, 2601709, 18585064.
27. Ribot JC, deBarros A, Pang DJ, Neves JF, Peperzak V, Roberts SJ, Girardi M, Borst J, Hayday AC, Pennington DJ. CD27 is a thymic determinant of the balance between interferon-gamma- and interleukin 17-producing gammadelta T cell subsets. Nat Immunol 2009, 10:427-36. 10.1038/ni.1717, 19270712.
28. Bonneville M. gammadelta T cell selection: is anyone useless?. Immunity 2008, 29:3-5. 10.1016/j.immuni.2008.06.007, 18631449.